Cargando…
Amyloid‐β PET in Alzheimer's disease: A systematic review and Bayesian meta‐analysis
BACKGROUND: In recent years, longitudinal studies of Alzheimer's disease (AD) have been successively concluded. Our aim is to determine the efficacy of amyloid‐β (Aβ) PET in diagnosing AD and early prediction of mild cognitive impairment (MCI) converting to AD. By pooling studies from different...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847612/ https://www.ncbi.nlm.nih.gov/pubmed/36573329 http://dx.doi.org/10.1002/brb3.2850 |